Our study included one case with highly heterogeneous immunohistochemical results displaying small foci of strong circumferential membranous HER2 staining (< 10% of tumor cells with 3 + staining), reported as 1 + according to ASCO/USCAP criteria but demonstrating HER2 amplification by subsequent CISH. The gene discussed is ERBB2; the disease is neoplasm.